Risk
By: anl213 • July 31, 2014 • Essay • 365 Words (2 Pages) • 1,078 Views
The last four questions involve "risk" and thus imply that some inputs are non-deterministic. Let's assume:
Market size: N(µ=2MM, ?=400K)
R&D costs: U(600MM, 800MM)
Clinical trial costs: LogNormal(µ=150MM, ?=30K)
Annual market growth: Tri(min = 2%, max = 6%, likely = 3%)
Annual market share growth rate: Tri(min = 15%, max = 25%, likely = 20%)
See Moore Pharmaceuticals.xlsx
The last four questions involve "risk" and thus imply that some inputs are non-deterministic. Let's assume:
Market size: N(µ=2MM, ?=400K)
R&D costs: U(600MM, 800MM)
Clinical trial costs: LogNormal(µ=150MM, ?=30K)
Annual market growth: Tri(min = 2%, max = 6%, likely = 3%)
Annual market share growth rate: Tri(min = 15%, max = 25%, likely = 20%)
See Moore Pharmaceuticals.xlsx
The last four questions involve "risk" and thus imply that some inputs are non-deterministic. Let's assume:
Market size: N(µ=2MM, ?=400K)
R&D costs: U(600MM, 800MM)
Clinical trial costs: LogNormal(µ=150MM, ?=30K)
Annual market growth: Tri(min = 2%, max = 6%, likely = 3%)
Annual market share growth rate: Tri(min = 15%, max = 25%, likely = 20%)
See Moore Pharmaceuticals.xlsx
vvThe last four questions involve "risk" and thus imply that some inputs are non-deterministic. Let's assume:
Market size: N(µ=2MM, ?=400K)
R&D costs: U(600MM, 800MM)
Clinical trial costs: LogNormal(µ=150MM, ?=30K)
Annual market growth: Tri(min = 2%, max = 6%, likely = 3%)
Annual market share growth rate: Tri(min = 15%, max = 25%, likely = 20%)
See Moore Pharmaceuticals.xlsx
The last four questions involve "risk" and thus imply that some inputs are non-deterministic. Let's assume:
...